Literature DB >> 2648493

Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies.

K Gill1, Z Amit.   

Abstract

Previous research demonstrated that serotonin uptake blockers (e.g., zimeldine, sertraline, fluoxetine) reduce voluntary ethanol consumption in rats and humans. However, the mechanism of action of these compounds is not well understood. It has been suggested, for example, that serotonin uptake blockade interferes with the processes that mediate the reinforcement derived from ethanol ingestion. On the other hand, there is considerable experimental evidence that suggests that the effects on alcohol intake may be an expression of a more general inhibitory role that serotonin plays in consummatory behavior. This chapter presents evidence that suggests that serotonin uptake blockers may affect ethanol intake, in part via a reduction of food intake. Current issues concerning the central versus peripheral mediation of these effects, receptor specificity, as well as alternate mechanisms of action are considered.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648493     DOI: 10.1007/978-1-4899-1678-5_12

Source DB:  PubMed          Journal:  Recent Dev Alcohol        ISSN: 0738-422X


  7 in total

1.  Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?

Authors:  Bankole A Johnson; Martin A Javors; John D Roache; Chamindi Seneviratne; Susan E Bergeson; Nassima Ait-Daoud; Michael A Dawes; Jennie Z Ma
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-08-19       Impact factor: 5.067

2.  Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration.

Authors:  Y Wang; N Joharchi; P J Fletcher; E M Sellers; G A Higgins
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

Review 3.  Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

Authors:  Bankole A Johnson
Journal:  Biochem Pharmacol       Date:  2007-08-09       Impact factor: 5.858

5.  Characterization of a functional polymorphism in the 3' UTR of SLC6A4 and its association with drinking intensity.

Authors:  Chamindi Seneviratne; Weihua Huang; Nassima Ait-Daoud; Ming D Li; Bankole A Johnson
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

6.  Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats.

Authors:  Dong Ji; Nicholas W Gilpin; Heather N Richardson; Catherine L Rivier; George F Koob
Journal:  Behav Pharmacol       Date:  2008-02       Impact factor: 2.293

Review 7.  Medications to treat alcoholism.

Authors:  B A Johnson; N Ait-Daoud
Journal:  Alcohol Res Health       Date:  1999
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.